These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

431 related articles for article (PubMed ID: 17849067)

  • 1. Report of a novel kindred with antithrombin heparin-binding site variant (47 Arg to His): demand for an automated progressive antithrombin assay to detect molecular variants with low thrombotic risk.
    Rossi E; Chiusolo P; Za T; Marietti S; Ciminello A; Leone G; De Stefano V
    Thromb Haemost; 2007 Sep; 98(3):695-7. PubMed ID: 17849067
    [No Abstract]   [Full Text] [Related]  

  • 2. Antithrombin Nagasaki (Ser 116 to Pro): a rare antithrombin variant with abnormal heparin binding presenting during pregnancy.
    O'Ddonnell JS; Hinkson L; McCarthy A; Manning R; Khan A; Laffan MA
    Blood Coagul Fibrinolysis; 2006 Apr; 17(3):217-20. PubMed ID: 16575261
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recurrent leg ulcers and arterial thrombosis in a 33-year-old homozygous variant of antithrombin.
    Shimizu K; Toriyama F; Ogawa F; Katayama I; Okajima K
    Am J Hematol; 2001 Apr; 66(4):285-91. PubMed ID: 11279641
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Homozygous or compound heterozygous qualitative antithrombin III deficiency.
    Cucuianu M; Blaga S; Pop S; Olinic D; Olinic N; Colhon D; Cristea A
    Nouv Rev Fr Hematol (1978); 1994 Aug; 36(4):335-7. PubMed ID: 7971256
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antithrombin heparin binding site deficiency: A challenging diagnosis of a not so benign thrombophilia.
    Orlando C; Heylen O; Lissens W; Jochmans K
    Thromb Res; 2015 Jun; 135(6):1179-85. PubMed ID: 25837307
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antithrombin III deficiency.
    Cucuianu M; Blaga S; Pop S; Olinic D; Olinic N; Colhon D; Cristea A
    Rom J Intern Med; 1994; 32(2):119-27. PubMed ID: 7920326
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Homozygous variant of antithrombin III that lacks affinity for heparin, AT III Kumamoto.
    Okajima K; Ueyama H; Hashimoto Y; Sasaki Y; Matsumoto K; Okabe H; Inoue M; Araki S; Takatsuki K
    Thromb Haemost; 1989 Feb; 61(1):20-4. PubMed ID: 2749590
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Amelioration of the severity of heparin-binding antithrombin mutations by posttranslational mosaicism.
    Martínez-Martínez I; Navarro-Fernández J; Østergaard A; Gutiérrez-Gallego R; Padilla J; Bohdan N; Miñano A; Pascual C; Martínez C; de la Morena-Barrio ME; Aguila S; Pedersen S; Kristensen SR; Vicente V; Corral J
    Blood; 2012 Jul; 120(4):900-4. PubMed ID: 22498748
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Antithrombin deficiency due to heterozygous antithrombin gene mutation and a pedigree study].
    Ye X; Feng Y; Jin PP; Zhou XH; Ding QL; Wang XF
    Zhonghua Xue Ye Xue Za Zhi; 2007 Sep; 28(9):587-9. PubMed ID: 18246812
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular bases of antithrombin deficiency: twenty-two novel mutations in the antithrombin gene.
    Picard V; Nowak-Göttl U; Biron-Andreani C; Fouassier M; Frere C; Goualt-Heilman M; de Maistre E; Regina S; Rugeri L; Ternisien C; Trichet C; Vergnes C; Aiach M; Alhenc-Gelas M
    Hum Mutat; 2006 Jun; 27(6):600. PubMed ID: 16705712
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Homozygous antithrombin deficiency type II (99 Leu to Phe mutation) and childhood thromboembolism.
    Kuhle S; Lane DA; Jochmanns K; Male C; Quehenberger P; Lechner K; Pabinger I
    Thromb Haemost; 2001 Oct; 86(4):1007-11. PubMed ID: 11686316
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular basis of antithrombin deficiency.
    Luxembourg B; Delev D; Geisen C; Spannagl M; Krause M; Miesbach W; Heller C; Bergmann F; Schmeink U; Grossmann R; Lindhoff-Last E; Seifried E; Oldenburg J; Pavlova A
    Thromb Haemost; 2011 Apr; 105(4):635-46. PubMed ID: 21264449
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel mutation of antithrombin deficiency in six family siblings and the clinical combat.
    Nadir Y; Hoffman R; Corral J; Barak Y; Hasin T; Keren-Politansky A; Brenner B
    Thromb Haemost; 2015 Oct; 114(4):859-61. PubMed ID: 26177694
    [No Abstract]   [Full Text] [Related]  

  • 14. Antithrombin Dublin (p.Val30Glu): a relatively common variant with moderate thrombosis risk of causing transient antithrombin deficiency.
    Navarro-Fernández J; de la Morena-Barrio ME; Padilla J; Miñano A; Bohdan N; Águila S; Martínez-Martínez I; Sevivas TS; de Cos C; Fernández-Mosteirín N; Llamas P; Asenjo S; Medina P; Souto JC; Overvad K; Kristensen SR; Corral J; Vicente V
    Thromb Haemost; 2016 Jul; 116(1):146-54. PubMed ID: 27098529
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Arterial and venous thrombosis and prothrombotic fibrin clot phenotype in a Polish family with type 1 antithrombin deficiency (antithrombin Krakow).
    Celinska-Lowenhoff M; Iwaniec T; Alhenc-Gelas M; Musial J; Undas A
    Thromb Haemost; 2011 Aug; 106(2):379-81. PubMed ID: 21655678
    [No Abstract]   [Full Text] [Related]  

  • 16. Impact of the type of SERPINC1 mutation and subtype of antithrombin deficiency on the thrombotic phenotype in hereditary antithrombin deficiency.
    Luxembourg B; Pavlova A; Geisen C; Spannagl M; Bergmann F; Krause M; Alesci S; Seifried E; Lindhoff-Last E
    Thromb Haemost; 2014 Feb; 111(2):249-57. PubMed ID: 24196373
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antithrombin gene mutation 5356-5364*delCTT with type I deficiency and early-onset thrombophilia and a brief review of the antithrombin alpha-helix D molecular pathology.
    Steiner M; Steiner B; Rolfs A; Wangnick M; Burstein C; Freund M; Schuff-Werner P
    Ann Hematol; 2005 Jan; 84(1):56-8. PubMed ID: 15309521
    [No Abstract]   [Full Text] [Related]  

  • 18. Creation of an additional glycosylation site as a mechanism for type I antithrombin deficiency.
    Fitches AC; Lewandowski K; Olds RJ
    Thromb Haemost; 2001 Oct; 86(4):1023-7. PubMed ID: 11686319
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Abnormal antithrombin III: abnormalities of heparin or protease binding domain].
    Sakuragawa N; Niiya K; Takahashi K; Hayashi T; Oguma Y; Saitoh S
    Rinsho Byori; 1993 May; 41(5):492-505. PubMed ID: 8350512
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic analysis should be included in clinical practice when screening for antithrombin deficiency.
    Zeng W; Tang L; Jian XR; Li YQ; Guo T; Wang QY; Liu H; Wu YY; Cheng ZP; Hu B; Lu X; Yu JM; Deng J; Wang HF; Sun CY; Yang Y; Hu Y
    Thromb Haemost; 2015 Feb; 113(2):262-71. PubMed ID: 25298121
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.